213 related articles for article (PubMed ID: 32612073)
1. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
[TBL] [Abstract][Full Text] [Related]
2. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
3. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
Kamei J; Nagase H
Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats.
Tian B; Wang XL; Huang Y; Chen LH; Cheng RX; Zhou FM; Guo R; Li JC; Liu T
Sci Rep; 2016 Nov; 6():36286. PubMed ID: 27824106
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of infliximab for pruritus in mice model of cholestasis induced by bile duct ligation: Possible involvement of IL-31.
Ebrahim Soltani Z; Elahi M; Khavandi M; Haddadi NS; Shayan M; Khalilzadeh M; Dehpour AR
Int Immunopharmacol; 2023 Oct; 123():110806. PubMed ID: 37597403
[TBL] [Abstract][Full Text] [Related]
6. Development of resistance to serotonin-induced itch in bile duct ligated mice.
Ostadhadi S; Haddadi NS; Foroutan A; Azimi E; Elmariah S; Dehpour AR
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):680-685. PubMed ID: 28316077
[TBL] [Abstract][Full Text] [Related]
7. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
8. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.
Inan S; Cowan A
Pharmacol Biochem Behav; 2006 Sep; 85(1):39-43. PubMed ID: 16919318
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and treatment of pruritus in cholestasis.
Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
[TBL] [Abstract][Full Text] [Related]
10. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
[TBL] [Abstract][Full Text] [Related]
11. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Togashi Y; Umeuchi H; Okano K; Ando N; Yoshizawa Y; Honda T; Kawamura K; Endoh T; Utsumi J; Kamei J; Tanaka T; Nagase H
Eur J Pharmacol; 2002 Jan; 435(2-3):259-64. PubMed ID: 11821035
[TBL] [Abstract][Full Text] [Related]
12. The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis.
Yurdakul Ertan H; Özbakış Dengiz G; Barut F; Yılmaz Ürün Y; Can M; Hussen SU; Üstündağ Y
Turk J Gastroenterol; 2023 Jan; 34(1):62-72. PubMed ID: 36098363
[TBL] [Abstract][Full Text] [Related]
13. Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice.
Yamaguchi T; Nagasawa T; Satoh M; Kuraishi Y
Neurosci Res; 1999 Nov; 35(2):77-83. PubMed ID: 10616911
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cholestatic pruritus in children.
Cies JJ; Giamalis JN
Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
[TBL] [Abstract][Full Text] [Related]
17. Pruritus in chronic cholestatic liver disease.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2012 May; 16(2):331-46. PubMed ID: 22541702
[TBL] [Abstract][Full Text] [Related]
18. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
Jones EA; Neuberger J; Bergasa NV
QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
[TBL] [Abstract][Full Text] [Related]
19. Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice.
Dehpour AR; Samini M; Arad MA; Namiranian K
Pharmacol Toxicol; 2001 Sep; 89(3):129-32. PubMed ID: 11589783
[TBL] [Abstract][Full Text] [Related]
20. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
